Bolognesi DP - Search Results

1

Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees.

Ferrari G, Place CA, Ahearne PM, Nigida SM Jr, Arthur LO, Bolognesi DP, Weinhold KJ. Ferrari G, et al. Among authors: bolognesi dp. J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):325-31. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8133445

2

Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.

Weinhold KJ, Lyerly HK, Matthews TJ, Tyler DS, Ahearne PM, Stine KC, Langlois AJ, Durack DT, Bolognesi DP. Weinhold KJ, et al. Among authors: bolognesi dp. Lancet. 1988 Apr 23;1(8591):902-5. doi: 10.1016/s0140-6736(88)91713-8. Lancet. 1988. PMID: 2895830

3

Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.

Tyler DS, Stanley SD, Bartlett JA, Bolognesi DP, Weinhold KJ. Tyler DS, et al. Among authors: bolognesi dp. J Surg Res. 1998 Oct;79(2):115-20. doi: 10.1006/jsre.1998.5415. J Surg Res. 1998. PMID: 9758725

4

Cellular immune response to viral peptides in patients exposed to HIV.

Ahearne PM, Matthews TJ, Lyerly HK, White GC, Bolognesi DP, Weinhold KJ. Ahearne PM, et al. Among authors: bolognesi dp. AIDS Res Hum Retroviruses. 1988 Aug;4(4):259-67. doi: 10.1089/aid.1988.4.259. AIDS Res Hum Retroviruses. 1988. PMID: 2462895

5

IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).

Ferrari G, King K, Rathbun K, Place CA, Packard MV, Bartlett JA, Bolognesi DP, Weinhold KJ. Ferrari G, et al. Among authors: bolognesi dp. Clin Exp Immunol. 1995 Aug;101(2):239-48. doi: 10.1111/j.1365-2249.1995.tb08345.x. Clin Exp Immunol. 1995. PMID: 7544247 Free PMC article.

6

Multiple CTL specificities against autologous HIV-1-infected BLCLs.

Ahearne PM, Morgan RA, Sebastian MW, Bolognesi DP, Weinhold KJ. Ahearne PM, et al. Among authors: bolognesi dp. Cell Immunol. 1995 Mar;161(1):34-41. doi: 10.1006/cimm.1995.1006. Cell Immunol. 1995. PMID: 7867083

7

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.

Ferrari G, Humphrey W, McElrath MJ, Excler JL, Duliege AM, Clements ML, Corey LC, Bolognesi DP, Weinhold KJ. Ferrari G, et al. Among authors: bolognesi dp. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1396-401. doi: 10.1073/pnas.94.4.1396. Proc Natl Acad Sci U S A. 1997. PMID: 9037064 Free PMC article.

8

Cytokine augmentation of human immunodeficiency virus type 1 (HIV-1) gp120-specific cellular cytotoxicity.

Stine KC, Bolognesi D, Weinhold KJ. Stine KC, et al. J Biol Response Mod. 1989 Oct;8(5):501-10. J Biol Response Mod. 1989. PMID: 2552026

9

Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.

Tyler DS, Stanley SD, Nastala CA, Austin AA, Bartlett JA, Stine KC, Lyerly HK, Bolognesi DP, Weinhold KJ. Tyler DS, et al. Among authors: bolognesi dp. J Immunol. 1990 May 1;144(9):3375-84. J Immunol. 1990. PMID: 2329275

10

HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.

Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP. Weinhold KJ, et al. Among authors: bolognesi dp. J Immunol. 1989 May 1;142(9):3091-7. J Immunol. 1989. PMID: 2468713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters